Sign in
Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays
Journal article   Peer reviewed

Comparison of detection and quantification of HBV DNA in chronic HBeAg negative and positive patients by Abbott RealTime HBV and Roche Cobas TaqMan HBV assays

Carol J Morris, Mary Hill, Maria de Medina, Christine Herman, Gavin A Cloherty and Paul Martin
Journal of virological methods, Vol.193(2), pp.391-393
2013-11
PMID: 23835030

Abstract

HBV viral load Cobas TaqMan HBV assay Abbott RealTime HBV assay HBeAg negative HBeAg positive
Monitoring the serum hepatitis B viral DNA levels with sensitive realtime PCR assays is strongly recommended for the management of patients with chronic HBV infection. This study compares the performance of two realtime HBV quantitative PCR assays with samples from chronic HBeAg(+) and HBeAg(−) patients.

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Industry collaboration
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.125 Hepatitis
1.125.275 HBV
Web Of Science research areas
Biochemical Research Methods
Biotechnology & Applied Microbiology
Virology
ESI research areas
Microbiology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details